Articles of Journal of Japanese Medical Society for Lung Surfactant and Biological Interface | Volume 55, Issue / 2024

Search by Journal

HOME
> Search by Journal
> Journal of Japanese Medical Society for Lung Surfactant and Biological Interface

Journal of Japanese Medical Society for Lung Surfactant and Biological Interface

Volume 55, Issue / 2024

English Article

Japanese Article

Please note that metadata of J-type articlesare generated by machine-translation and the original texts are written in Japanese.

	1. Interaction of the carbohydrate chain of pulmonary surfactant protein D and the receptor tyrosine kinase 長谷川喜弘 Journal of Japanese Medical Society for Lung Surfactant and Biological Interface 55: 1-5, 2024.

	2. A role and limit of the immunoprophylaxis of the lungs in the pulmonary nontuberculous acid-fast bacterium disease 森本耕三 Journal of Japanese Medical Society for Lung Surfactant and Biological Interface 55: 6-7, 2024.

	3. Lung disease and Mucosal-associated invariant T (MAIT) cells 原田紀宏 Journal of Japanese Medical Society for Lung Surfactant and Biological Interface 55: 8-10, 2024.

	A natural immunity reply and cholesterol for viral infections 押海裕之 Journal of Japanese Medical Society for Lung Surfactant and Biological Interface 55: 11-16, 2024.

	1. Maintenance of the health of the lungs by the life course approach 今野哲 Journal of Japanese Medical Society for Lung Surfactant and Biological Interface 55: 17-18, 2024.

	2. The impact that a pulmonary surfactant study brought for an interstitial lung disease diagnosis 高橋弘毅 Journal of Japanese Medical Society for Lung Surfactant and Biological Interface 55: 19-24, 2024.

	It is ... including the directionality of the study of microbiotic formation - future in respiratory illness 小林哲 Journal of Japanese Medical Society for Lung Surfactant and Biological Interface 55: 25-28, 2024.

	1. Effect of Glucocorticoid on alveolar cells healing of wound 沓澤直賢, 伊藤洋子, 加川志津子, 浅野浩一郎 Journal of Japanese Medical Society for Lung Surfactant and Biological Interface 55: 29-29, 2024.

	2. Is complicated with COVID-19 infection for alveolar proteinosis; a case receiving Remdesivir 大崎優亮 Journal of Japanese Medical Society for Lung Surfactant and Biological Interface 55: 30-30, 2024.

	3. Physicochemical characteristic effect in the pulmonary disorder of the acrylic acid-based high molecular compound 友永泰介1), 和泉弘人1), 川合直紀1), 佐藤和真1), 西田千夏2), 東秀憲2), 森本俊規3), 東泰幸3), 矢寺和博3), 森本泰夫1) Journal of Japanese Medical Society for Lung Surfactant and Biological Interface 55: 31-33, 2024.

	4. The mucous membrane Adjuvant SF-10 mixture new model corona vaccine transrespiratory tract administration derived from human pulmonary surfactant induces high respiratory tract mucosa phylaxis immunity in the mouse at infants, old age 木本貴士1,2), 堺聡子2), 亀田桂子2), 高橋悦久2), 澤淵貴子2), 木戸博2) Journal of Japanese Medical Society for Lung Surfactant and Biological Interface 55: 34-35, 2024.

4. The mucous membrane Adjuvant SF-10 mixture new model corona vaccine transrespiratory tract administration derived from human pulmonary surfactant induces high respiratory tract mucosa phylaxis immunity in the mouse at infants, old age
木本貴士1,2), 堺聡子2), 亀田桂子2), 高橋悦久2), 澤淵貴子2), 木戸博2)
Journal of Japanese Medical Society for Lung Surfactant and Biological Interface 55: 34-35, 2024.

	5. Association of an SP-D level and the Microbiota in BAIF in the pulmonary sarcoidosis 齊藤正興1), 春日啓介1), 宮岡智花1), 麻生純平1), 布川寛樹1), 佐田充1), 中本啓太郎1), 皿谷健1), 大崎敬子2), 石井晴之1) Journal of Japanese Medical Society for Lung Surfactant and Biological Interface 55: 36-36, 2024.

ID
Password